Equity Analysis /
United States of America

US : Sarepta Therapeutics, Inc. - SRPT | SRP-9001 Updates at WMS: Taking a Cautious View of 3-Year Functional Data from OL Study-101

    Danielle Brill
    CGS-CIMB
    20 September 2021
    Published by